Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America

Published:2019 Issue:2 Volume:12 Page:100011
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Cherrez-Ojeda Ivan,Maurer Marcus,Bernstein Jonathan A.,Vanegas Emanuel,Felix Miguel,Ramon German D.,Ensina Luis Felipe,Larco Sousa José Ignacio,Matos Benavides Edgar Emilio,Cardona Villa R.,Latour Staffeld P.,Morfin-Maciel Blanca María,Mori Jose,Wilches C Paul,Mata Valeria L.,Cherrez Annia

Funder

Allakos

Aralez

Genentech

GSK

Menarini

Merckle Recordati

Moxie

Novartis

Sanofi

MSD

Uriach

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference33 articles.

1. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria;Zuberbier;Allergy,2018

2. Treatment of chronic autoimmune urticaria with omalizumab;Kaplan;J Allergy Clin Immunol,2008

3. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase;Maurer;J Allergy Clin Immunol,2011

4. Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema;Maurer;J Eur Acad Dermatol Venereol : JEADV,2017

5. The XTEND-CIU study: long-term use of omalizumab in chronic idiopathic urticaria;Maurer;J Allergy Clin Immunol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment;The Lancet;2024-07

2. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema;Journal of the European Academy of Dermatology and Venereology;2024-06-10

3. Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia;Frontiers in Allergy;2022-05-20

4. Expert consensus on the use of omalizumab in chronic urticaria in China;World Allergy Organization Journal;2021-11

5. Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both;World Allergy Organization Journal;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3